Methylation anomalies in cancerogenesis: search for new genes, development of methods and DNA-markers for diagnosis
Author(s) -
Zaletaev Dv,
V. V. Strelnikov,
Т. В. Кекеева,
В В Землякова,
Ekaterina Kuznetsova,
Dmitri S Mikhaylenko
Publication year - 2011
Publication title -
ecological genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.148
H-Index - 3
eISSN - 2411-9202
pISSN - 1811-0932
DOI - 10.17816/ecogen9327-32
Subject(s) - epigenetics , methylation , dna methylation , biology , gene , genetics , suppressor , tumor suppressor gene , microbiology and biotechnology , cancer research , carcinogenesis , gene expression
The report considers the epigenetic defects and their diagnostics in tumors. Aberrant methylation of the promoter or regulatory region of a gene results in its functional inactivation, which is phenotypically similar to structural deletion. Cancerogenesis-associated genes are often methylated in tumors. Tumors differ in methylation frequencies, allowing differential diagnostics. Aberrant methylation of tumor suppressor genes occurs in early cancerogenesis, and its detection may be employed in presymptomatic and noninvasive diagnostics of tumors.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom